Item 1 of 28 (back to results) next dipotassium clorazepate The compound of monopotassium clorazepate with potassium hydroxide. It is used for the management of anxiety disorders, for the short-term relief of anxiety, as adjunctive therapy in the management of epilepsy, and for the symptomatic relief of acute alcohol withdrawal.

Current search: 08. Chemical Category: main group molecular entity [CHEBI:33579] > s-block molecular entity [CHEBI:33674] > alkali metal molecular entity [CHEBI:33296] > potassium molecular entity [CHEBI:26217] × Select any link to see items in a related category. more general categories    information about this item 03. Biological Effects of Specific Chemicals  03. Biological Effects of Specific Chemicals  biophysical uses [CHEBI:52208] (136)   membrane transport modulator [CHEBI:38632] (122)   GABA modulator [CHEBI:50268] (9)   dipotassium clorazepate [CHEBI:3762] (1) 05. Industrial Uses  05. Industrial Uses  pharmaceutical [CHEBI:52217] (1978)   drug [CHEBI:23888] (1930)   central nervous system drug [CHEBI:35470] (217)   psychotropic drug [CHEBI:35471] (130)   tranquilizing drug [CHEBI:35473] (83)   anxiolytic drug [CHEBI:35474] (31)   dipotassium clorazepate [CHEBI:3762] (1)  central nervous system depressant [CHEBI:35488] (90)   anticonvulsant [CHEBI:35623] (39)   dipotassium clorazepate [CHEBI:3762] (1)  prodrug [CHEBI:50266] (88)   dipotassium clorazepate [CHEBI:3762] (1) 08. Chemical Category  08. Chemical Category  main group molecular entity [CHEBI:33579] (25650)   s-block molecular entity [CHEBI:33674] (7287)   alkali metal molecular entity [CHEBI:33296] (279)   potassium molecular entity [CHEBI:26217] (28)   potassium salt [CHEBI:26218] (26)   dipotassium clorazepate [CHEBI:3762] (1)  alkali metal salt [CHEBI:35479] (248)   potassium salt [CHEBI:26218] (26)   dipotassium clorazepate [CHEBI:3762] (1)  polyatomic entity [CHEBI:36357] (18777)   heteroatomic molecular entity [CHEBI:37577] (13672)   salt [CHEBI:24866] (931)   alkali metal salt [CHEBI:35479] (248)   potassium salt [CHEBI:26218] (26)   dipotassium clorazepate [CHEBI:3762] (1) ChEBI Compound Accession Identifier:   [CHEBI:3762] ChEBI Compound Description:   The compound of monopotassium clorazepate with potassium hydroxide. It is used for the management of anxiety disorders, for the short-term relief of anxiety, as adjunctive therapy in the management of epilepsy, and for the symptomatic relief of acute alcohol withdrawal. ChEBI Compound Identification Number:   3762 ChEBI InChI Value:   "InChI=1S/C16H11ClN2O3.2K.H2O/c17-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)19-14(16(21)22)15(20)18-12;;;/h1-8,14H,(H,18,20)(H,21,22);;;1H2/q;2*+1;/p-2" ChEBI InChIKey Value:   QCHSEDTUUKDTIG-UHFFFAOYSA-L ChEBI Compound Name:   dipotassium clorazepate ChEBI SMILES Value:   [OH-].[K+].[K+].[O-]C(=O)C1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O ChEBI Substance ID:   96079577 ChEBI URL:   ChEBI:3762 ChemSpider ID:   NS Ontomatica Chemical Accession Key (OnChAKey):   QCHSEDTUUKDTIG_UHFFFAOYSA_L_000_000000 PubChem Compound ID:   167305